NCT05632263 (EHMRGscore) is a clinical trial of EHMRGscore in Emergencies, sponsored by University of Monastir.

Who is sponsoring NCT05632263?

NCT05632263 is sponsored by University of Monastir.

What drugs are being tested in NCT05632263?

Interventions in NCT05632263: EHMRGscore.

What condition does NCT05632263 study?

NCT05632263 studies Emergencies, Heart Diseases.

Is NCT05632263 still recruiting?

NCT05632263 is currently status unknown. Last updated 14 March 2023.

Last reviewed 2023-03-14 · How we verify

NCT05632263: EHMRGscore

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate the Predictive Impact of the EHMRG

Status unknown Last updated 14 March 2023

What this trial tests

trial testing EHMRGscore in Emergencies in 1,500 participants. Status unknown.

Timeline

30 April 2023

Primary endpoint
30 November 2023

15 December 2023

Quick facts

Lead sponsor	University of Monastir
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,500
Start date	30 April 2023
Primary completion	30 November 2023
Estimated completion	15 December 2023

Drugs / interventions tested

EHMRGscore

Conditions studied

Emergencies — all drugs for Emergencies →
Heart Diseases — all drugs for Heart Diseases →

Sponsor

University of Monastir

Who can join

Adults 18 to 95, any sex, with Emergencies or Heart Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

External validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Emergencies

Currently open trials in the same condition.

NCT06565390 — Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization · NA · recruiting
NCT07051668 — The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls · NA · recruiting
NCT06680778 — Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch · recruiting
NCT07008391 — High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS · NA · recruiting
NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting

Other University of Monastir trials

Trials by the same sponsor.

NCT07345156 — Congestion and LActate at diScHarge in Acute Heart Failure · not yet recruiting
NCT07181642 — Diaphragmatic Breathing for Sleep Bruxism in Adults: A Randomized Controlled Trial · NA · completed
NCT06980727 — Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED · Phase 3 · not yet recruiting
NCT06900972 — Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial · Phase 3 · enrolling by invitation
NCT06723002 — Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05632263 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Monastir
Last refreshed: 14 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05632263.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing